These U.S. and Canadian companies are scheduled to report their quarterly earnings today. Below is a preview of their key earning metrics, based on consensus estimates of analysts polled by Bloomberg. We have also provided analysts’ consensus buy ratings for these stocks with upside/downside potential for the upcoming 12-months.
| Company | Ticker | Exchange | Market Cap (MM) |
Last Price | Industry | Reporting Time |
Quarter | Sales ($MM) (Growth) |
Net Income ($MM) (Growth) |
EPS ($) (Growth) |
Total Analyst Coverage |
Buy Ratings | Upside Potential |
| Rockwood Holdings Inc | ROC | NYSE | 5,772.2 | 78.88 | Chemicals-Diversified | NA | 13Q4 | 342.29 (-58.7%) |
24.60 (16.0%) |
0.33 (26.9%) |
8 | 63% | 3.2% |
| Stillwater Mining Co | SWC | NYSE | 1,615.6 | 13.54 | Platinum | BMO | 13Q4 | 243.50 (19.7%) |
7.10 (-58.5%) |
0.05 (-61.5%) |
6 | 67% | 18.2% |
| Molycorp Inc | MCP | NYSE | 1,219.2 | 5.22 | Metal-Diversified | AMC | 13Q4 | 148.25 (10.4%) |
-52.85 (85.4%) |
-0.41 (85.9%) |
10 | 20% | -23.4% |
| EV Energy Partner LP | EVEP | NASDAQ | 1,696.1 | 35.08 | Oil Comp-Explor&Prodtn | BMO | 13Q4 | 90.68 (20.1%) |
11.10 (NM) |
0.19 (NM) |
12 | 58% | 21.2% |
| QR Energy LP | QRE | NYSE | 1,135.7 | 17.54 | Oil Comp-Explor&Prodtn | BMO | 13Q4 | 129.80 (33.3%) |
25.80 (1232.0%) |
0.36 (NM) |
16 | 63% | 15.2% |
| JinkoSolar Holding Co Ltd | JKS | NYSE | 1,006.6 | 32.72 | Energy-Alternate Sources | BMO | 13Q4 | 2103.79 (80.2%) |
123.68 (NM) |
4.97 (NM) |
5 | 80% | 33.0% |
| Stratasys Ltd | SSYS | NASDAQ | 6,117.5 | 127.13 | Computers-Peripher Equip | NA | 13Q4 | 151.32 (112.7%) |
-0.73 (82.8%) |
-0.01 (96.3%) |
22 | 77% | 13.6% |
| Guidewire Software Inc | GWRE | NYSE | 3,590.7 | 53.61 | Enterprise Software/Serv | AMC | 14Q2 | 77.36 (7.2%) |
-10.19 (-285.1%) |
-0.15 (-266.7%) |
6 | 67% | -7.2% |
| Perion Network Ltd | PERI | NASDAQ | 801.9 | 11.93 | Internet Applic Sftwr | BMO | 13Q4 | 29.60 (38.5%) |
1.67 (180.8%) |
0.08 (50.0%) |
4 | 100% | 50.9% |
| URS Corp | URS | NYSE | 3,482.1 | 46.50 | Engineering/R&D Services | AMC | 13Q4 | 2679.92 (-9.8%) |
13.38 (-81.0%) |
0.17 (-82.3%) |
15 | 27% | -0.5% |
| McDermott International Inc | MDR | NYSE | 1,970.7 | 8.33 | Engineering/R&D Services | AMC | 13Q4 | 830.58 (-16.6%) |
42.78 (5.5%) |
0.16 (-4.1%) |
18 | 22% | 8.8% |
| DXP Enterprises Inc | DXPE | NASDAQ | 1,447.4 | 101.76 | Machinery-General Indust | 16:00 | 13Q4 | 328.00 (11.9%) |
16.30 (15.8%) |
1.06 (14.9%) |
4 | 25% | 16.9% |
| Seaspan Corp | SSW | NYSE | 2,023.0 | 21.81 | Transport-Marine | 07:00 | 13Q4 | 171.29 (0.9%) |
23.95 (-59.4%) |
0.23 (-61.0%) |
13 | 31% | 16.5% |
| Sun Hydraulics Corp | SNHY | NASDAQ | 1,114.5 | 42.30 | Metal Processors&Fabrica | AMC | 13Q4 | 49.00 (13.3%) |
8.60 (28.5%) |
0.33 (26.9%) |
3 | 33% | 1.7% |
| Accuride Corp | ACW | NYSE | 209.5 | 4.41 | Auto/Trk Prts&Equip-Orig | BMO | 13Q4 | 150.50 (-14.6%) |
-9.82 (93.7%) |
-0.21 (93.8%) |
3 | 33% | NA |
| Mindray Medical International Ltd | MR | NYSE | 4,203.3 | 34.94 | Patient Monitoring Equip | AMC | 13Q4 | 366.00 (15.8%) |
58.00 (3.9%) |
NA | 16 | 69% | 15.8% |
| Akorn Inc | AKRX | NASDAQ | 2,487.9 | 25.82 | Medical-Drugs | BMO | 13Q4 | 83.43 (16.7%) |
12.83 (45.6%) |
0.12 (43.8%) |
9 | 67% | 5.3% |
| Celldex Therapeutics Inc | CLDX | NASDAQ | 2,598.3 | 29.22 | Medical-Biomedical/Gene | BMO | 13Q4 | 0.34 (-90.7%) |
-24.57 (-46.2%) |
-0.28 (-3.0%) |
10 | 90% | 28.1% |
| Synageva BioPharma Corp | GEVA | NASDAQ | 3,524.7 | 114.67 | Medical-Biomedical/Gene | AMC | 13Q4 | 2.12 (-56.5%) |
-29.76 (-95.9%) |
-1.01 (-63.1%) |
10 | 70% | -14.9% |
| Magellan Health Services Inc | MGLN | NASDAQ | 1,654.9 | 61.14 | Medical-HMO | 06:30 | 13Q4 | 985.75 (18.7%) |
22.73 (-38.6%) |
0.83 (-36.9%) |
7 | 14% | -1.2% |
| NuVasive Inc | NUVA | NASDAQ | 1,639.7 | 36.75 | Medical Instruments | AMC | 13Q4 | 189.00 (14.0%) |
5.55 (NM) |
0.11 (NM) |
23 | 43% | 2.5% |
| PDL BioPharma Inc | PDLI | NASDAQ | 1,200.2 | 8.57 | Medical-Biomedical/Gene | AMC | 13Q4 | 108.75 (26.4%) |
61.45 (24.4%) |
0.41 (20.6%) |
5 | 0% | -13.7% |
| Dendreon Corp | DNDN | NASDAQ | 453.6 | 2.88 | Medical-Biomedical/Gene | NA | 13Q4 | 72.76 (-14.9%) |
-56.26 (-45.4%) |
-0.37 (-41.2%) |
25 | 16% | 16.4% |
| AcelRx Pharmaceuticals Inc | ACRX | NASDAQ | 491.9 | 11.43 | Medical-Drugs | AMC | 13Q4 | 0.18 (-89.3%) |
-7.01 (33.4%) |
-0.18 (57.1%) |
9 | 89% | 38.1% |
| Amicus Therapeutics Inc | FOLD | NASDAQ | 162.2 | 2.52 | Medical-Drugs | NA | 13Q4 | NA | -16.35 (-63.3%) |
-0.34 (-68.5%) |
6 | 33% | 45.5% |
| RadNet Inc | RDNT | NASDAQ | 77.8 | 1.94 | MRI/Medical Diag Imaging | NA | 13Q4 | 173.00 (4.4%) |
-0.29 (-100.5%) |
-0.01 (-100.7%) |
3 | 33% | 86.9% |
| MBIA Inc | MBI | NYSE | 2,605.0 | 13.55 | Financial Guarantee Ins | AMC | 13Q4 | 227.00 (-69.0%) |
33.42 (-94.7%) |
0.17 (-94.8%) |
5 | 60% | 47.6% |
| Preferred Apartment Communities Inc | APTS | NYSE | 122.3 | 8.20 | REITS-Apartments | AMC | 13Q4 | 9.53 (153.9%) |
NA | -0.03 (-175.0%) |
3 | 100% | 28.0% |
| ZipRealty Inc | ZIPR | NASDAQ | 102.2 | 4.74 | Real Estate Mgmnt/Servic | 16:00 | 13Q4 | 16.85 ( N/A) |
-3.41 (N/A) |
-0.15 (N/A) |
3 | 67% | 68.8% |
| AuRico Gold Inc | AUQ | TSX | 1,354.0 | 5.46 | Gold Mining | AMC | 13Q4 | 63.73 (1.0%) |
3.20 (NM) |
0.02 (NM) |
15 | 60% | 7.3% |
| Geodrill Ltd | GEO | TSX | 40.4 | 0.95 | Mining Services | BMO | 13Q4 | 7.10 (-45.1%) |
NA | NA | 4 | 75% | NA |
| Pengrowth Energy Corp | PGF | TSX | 3,900.5 | 7.46 | Oil Comp-Explor&Prodtn | BMO | 13Q4 | 317.00 (-12.4%) |
-24.90 (-634.2%) |
-0.05 (-550.0%) |
20 | 40% | 4.1% |
Source: Bloomberg
Note: Sales, Net Income & EPS are Bloomberg estimated figures and the growth rates mentioned are year-over-year.
BMO: Before Market Open
NA: Not Available
NM: Not Meaningful
